A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this clinical trial is to learn which dose of study drug IBIO-610 has the right balance of safety, tolerability and impact on body composition in participants with obesity.
Epistemonikos ID: 34f7a718bd7e4527927df1c46cb6c2870851d121
First added on: Oct 23, 2026